Question

In: Accounting

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows:

1

Dec. 31, 20Y3

Dec. 31, 20Y2

2

Assets

3

Cash

$626,170.00

$585,760.00

4

Accounts receivable (net)

227,840.00

208,880.00

5

Inventories

641,390.00

616,790.00

6

Investments

0.00

240,820.00

7

Land

327,380.00

0.00

8

Equipment

704,290.00

554,020.00

9

Accumulated depreciation-equipment

(167,160.00)

(148,930.00)

10

Total assets

$2,359,910.00

$2,057,340.00

11

Liabilities and Stockholders’ Equity

12

Accounts payable (merchandise creditors)

$424,670.00

$404,080.00

13

Accrued expenses payable (operating expenses)

43,080.00

52,050.00

14

Dividends payable

24,920.00

19,300.00

15

Common stock, $4 par

140,000.00

102,000.00

16

Paid-in capital: Excess of issue price over par—common stock

417,400.00

280,600.00

17

Retained earnings

1,309,840.00

1,199,310.00

18

Total liabilities and stockholders’ equity

$2,359,910.00

$2,057,340.00

Additional data obtained from an examination of the accounts in the ledger for 20Y3 are as follows:

A. The investments were sold for $279,890 cash.
B. Equipment and land were acquired for cash.
C. There were no disposals of equipment during the year.
D. The common stock was issued for cash.
E. There was a $206,210 credit to Retained Earnings for net income.
F. There was a $95,680 debit to Retained Earnings for cash dividends declared.

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

`````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````````

Prepare a statement of cash flows, using the indirect method of presenting cash flows from operating activities. Refer to the Labels and Amount Descriptions list provided for the exact wording of the answer choices for text entries. Be sure to complete the heading of the statement. Use the minus sign to indicate cash out flows, cash payments, decreases in cash, or any negative adjustments.

Livers Inc.

Statement of Cash Flows

1

Cash flows from operating activities:

2

3

Adjustments to reconcile net income to net cash flow from operating activities:

4

5

6

Changes in current operating assets and liabilities:

7

8

9

10

11

12

13

Cash flows from investing activities:

14

15

16

17

18

19

Cash flows from financing activities:

20

21

22

23

24

Cash at the beginning of the year

25

Cash at the end of the year

---------------------------------------------------------------------------------------------------------------------

Labels and Amount Descriptions
Cash paid for dividends
Cash paid for merchandise
Cash paid for purchase of equipment
Cash paid for purchase of land
Cash received from customers
Cash received from sale of common stock
Cash received from sale of investments
Change in cash
December 31, 20Y3
Decrease in accounts payable
Decrease in accounts receivable
Decrease in accrued expenses payable
Decrease in inventories
Depreciation
For the Year Ended December 31, 20Y3
Gain on sale of investments
Increase in accounts payable
Increase in accounts receivable
Increase in accrued expenses payable
Increase in inventories
Loss on sale of investments
Net cash flow from operating activities
Net cash flow used for operating activities
Net cash flow from investing activities
Net cash flow used for investing activities
Net cash flow from financing activities
Net cash flow used for financing activities
Net income
Net loss

Solutions

Expert Solution

Solution

Livers Inc

Statement of cash flows:

Livers Inc

Statement of Cash Flows (Indirect Method)

for the year ended December 31, 20Y3

Cash flows from operating activities:

Net Income

206,210

Adjustments to reconcile net income to net cash flow from operating activities:

Depreciation expense

$18,230

gain on sale of investments

($39,070)

Changes in current operating assets and liabilities:

Increase in accounts receivable

($18,960)

Increase in inventory

($24,600)

increase in accounts payable

$20,590

decrease in accrued expenses payable

($8,970)

increase in dividends payable

$5,620

-$47,160

Cash flow from operating activities

$159,050

Cash flow from investing activities:

Proceeds from sale of investment

$279,890

Purchase of land

($327,380)

Purchase of equipment

($150,270)

Cash flow from investing activities

($197,760)

Cash flow from financing activities:

Issue of common stock

$174,800

Dividends paid

($95,680)

Cash flow from financing activities

$79,120

Excess of cash

$40,410

Beginning balance

$585,760

Ending cash balance

$626,170

Note:

Cash from issue of common stock –

Increase in common stock par value = $38,000(140,000 – 102,000)

Add: increase in paid-in capital$136,800(417,400 – 280,600)

Cash from issue of common stock$174,800

Gain on sale of investments:

Sale proceeds$279,890

Less: Book value $240,820

Gain on sale $39,070

Depreciation expense and gain on sale of investments are non-cash items and hence added back to reconcile net income.


Related Solutions

The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $155,000.00 $150,000.00 4 Accounts receivable (net) 450,000.00 400,000.00 5 Inventories 770,000.00 750,000.00 6 Investments 0.00 100,000.00 7 Land 500,000.00 0.00 8 Equipment 1,400,000.00 1,200,000.00 9 Accumulated depreciation-equipment (600,000.00) (500,000.00) 10 Total assets $2,675,000.00 $2,100,000.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $340,000.00 $300,000.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $262,580 $246,510 Accounts receivable (net) 95,120 88,540 Inventories 268,530 262,130 Investments 0 101,560 Land 137,730 0 Equipment 296,270 231,760 Accumulated depreciation—equipment (69,360) (62,500) Total assets $990,870 $868,000 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $179,350 $171,000 Accrued expenses payable (operating expenses) 17,840 22,570 Dividends payable 9,910 7,810 Common stock, $10 par 53,510 42,530 Paid-in...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,100.00 $585,190.00 4 Accounts receivable (net) 228,630.00 208,060.00 5 Inventories 641,030.00 617,620.00 6 Investments 0.00 239,830.00 7 Land 328,160.00 0.00 8 Equipment 705,110.00 553,850.00 9 Accumulated depreciation-equipment (166,840.00) (147,700.00) 10 Total assets $2,362,190.00 $2,056,850.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $423,690.00 $404,660.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,080.00 $586,430.00 4 Accounts receivable (net) 228,260.00 209,470.00 5 Inventories 641,070.00 616,400.00 6 Investments 0.00 240,170.00 7 Land 327,640.00 0.00 8 Equipment 705,000.00 552,830.00 9 Accumulated depreciation-equipment (165,670.00) (148,610.00) 10 Total assets $2,361,380.00 $2,056,690.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,090.00 $405,900.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $626,640.00 $585,760.00 4 Accounts receivable (net) 226,900.00 208,390.00 5 Inventories 641,350.00 616,130.00 6 Investments 0.00 239,300.00 7 Land 328,730.00 0.00 8 Equipment 705,940.00 553,530.00 9 Accumulated depreciation-equipment (166,970.00) (148,000.00) 10 Total assets $2,362,590.00 $2,055,110.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,140.00 $404,540.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: Dec. 31, 20Y3 Dec. 31, 20Y2 Assets Cash $306,450 $282,770 Accounts receivable (net) 111,020 101,560 Inventories 313,390 300,700 Investments 0 116,490 Land 160,740 0 Equipment 345,770 265,850 Accumulated depreciation—equipment (80,950) (71,690) Total assets $1,156,420 $995,680 Liabilities and Stockholders' Equity Accounts payable (merchandise creditors) $209,310 $196,150 Accrued expenses payable (operating expenses) 20,820 25,890 Dividends payable 11,560 8,960 Common stock, $10 par 62,450 48,790 Paid-in...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,680.00 $586,230.00 4 Accounts receivable (net) 228,100.00 208,850.00 5 Inventories 640,910.00 617,650.00 6 Investments 0.00 240,620.00 7 Land 328,090.00 0.00 8 Equipment 704,540.00 553,320.00 9 Accumulated depreciation-equipment (166,310.00) (147,840.00) 10 Total assets $2,361,010.00 $2,058,830.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $425,280.00 $404,550.00 13 Accrued expenses payable (operating expenses)...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as...
The comparative balance sheet of Livers Inc. for December 31, 20Y3 and 20Y2, is shown as follows: 1 Dec. 31, 20Y3 Dec. 31, 20Y2 2 Assets 3 Cash $625,650.00 $586,340.00 4 Accounts receivable (net) 228,170.00 208,030.00 5 Inventories 641,480.00 617,130.00 6 Investments 0.00 240,290.00 7 Land 328,170.00 0.00 8 Equipment 706,070.00 552,300.00 9 Accumulated depreciation-equipment (165,580.00) (147,010.00) 10 Total assets $2,363,960.00 $2,057,080.00 11 Liabilities and Stockholders’ Equity 12 Accounts payable (merchandise creditors) $424,300.00 $404,860.00 13 Accrued expenses payable (operating expenses)...
ADVERTISEMENT
ADVERTISEMENT
ADVERTISEMENT